 | • レポートコード：MRC2-11QY04214 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は心膜炎のグローバル市場について調査・分析したレポートです。種類別（急性心膜炎、慢性心膜炎、再発性心膜炎）市場規模、用途別（病院・診療所、医療機関、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別心膜炎の競争状況、市場シェア ・世界の心膜炎市場：種類別市場規模 2015年-2020年（急性心膜炎、慢性心膜炎、再発性心膜炎） ・世界の心膜炎市場：種類別市場規模予測 2021年-2026年（急性心膜炎、慢性心膜炎、再発性心膜炎） ・世界の心膜炎市場：用途別市場規模 2015年-2020年（病院・診療所、医療機関、研究機関） ・世界の心膜炎市場：用途別市場規模予測 2021年-2026年（病院・診療所、医療機関、研究機関） ・北米の心膜炎市場分析：米国、カナダ ・ヨーロッパの心膜炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの心膜炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の心膜炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの心膜炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Astrazeneca、Bayer、Reckitt Benckiser、Perkinelmer、Fujifilm、Merck Sharp & Dohme、Allergan ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other symptoms may include fever, weakness, palpitations, and shortness of breath. Occasionally onset of symptoms is gradual.
Treatment in most cases is with NSAIDs and possibly colchicine. Steroids may be used if those are not appropriate. Typically symptoms improve in a few days to weeks but can occasionally last months. Complications can include cardiac tamponade, myocarditis, and constrictive pericarditis. It is a less common cause of chest pain. About 3 per 10,000 people are affected per year. Those most commonly affected are males between the ages of 20 and 50. Up to 30% of those affected have more than one episode.
Market Analysis and Insights: Global Pericarditis Market
The global Pericarditis market size is projected to reach US$ 2021.5 million by 2026, from US$ 1927.5 million in 2020, at a CAGR of 4.5%% during 2021-2026.
Global Pericarditis Scope and Market Size
Pericarditis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pericarditis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Astrazeneca
Bayer
Reckitt Benckiser
Perkinelmer
Fujifilm
Merck Sharp & Dohme
Allergan
Market segment by Type, the product can be split into
Acute Pericarditis
Chronic Pericarditis
Recurrent Pericarditis
Market segment by Application, split into
Hospitals & Clinics
Medical Institutes
Research Organization
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pericarditis Revenue
1.4 Market by Type
1.4.1 Global Pericarditis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Pericarditis
1.4.3 Chronic Pericarditis
1.4.4 Recurrent Pericarditis
1.5 Market by Application
1.5.1 Global Pericarditis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinics
1.5.3 Medical Institutes
1.5.4 Research Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pericarditis Market Perspective (2015-2026)
2.2 Global Pericarditis Growth Trends by Regions
2.2.1 Pericarditis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pericarditis Historic Market Share by Regions (2015-2020)
2.2.3 Pericarditis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pericarditis Market Growth Strategy
2.3.6 Primary Interviews with Key Pericarditis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pericarditis Players by Market Size
3.1.1 Global Top Pericarditis Players by Revenue (2015-2020)
3.1.2 Global Pericarditis Revenue Market Share by Players (2015-2020)
3.1.3 Global Pericarditis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pericarditis Market Concentration Ratio
3.2.1 Global Pericarditis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pericarditis Revenue in 2019
3.3 Pericarditis Key Players Head office and Area Served
3.4 Key Players Pericarditis Product Solution and Service
3.5 Date of Enter into Pericarditis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pericarditis Historic Market Size by Type (2015-2020)
4.2 Global Pericarditis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pericarditis Market Size by Application (2015-2020)
5.2 Global Pericarditis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pericarditis Market Size (2015-2020)
6.2 Pericarditis Key Players in North America (2019-2020)
6.3 North America Pericarditis Market Size by Type (2015-2020)
6.4 North America Pericarditis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pericarditis Market Size (2015-2020)
7.2 Pericarditis Key Players in Europe (2019-2020)
7.3 Europe Pericarditis Market Size by Type (2015-2020)
7.4 Europe Pericarditis Market Size by Application (2015-2020)
8 China
8.1 China Pericarditis Market Size (2015-2020)
8.2 Pericarditis Key Players in China (2019-2020)
8.3 China Pericarditis Market Size by Type (2015-2020)
8.4 China Pericarditis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pericarditis Market Size (2015-2020)
9.2 Pericarditis Key Players in Japan (2019-2020)
9.3 Japan Pericarditis Market Size by Type (2015-2020)
9.4 Japan Pericarditis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pericarditis Market Size (2015-2020)
10.2 Pericarditis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pericarditis Market Size by Type (2015-2020)
10.4 Southeast Asia Pericarditis Market Size by Application (2015-2020)
11 India
11.1 India Pericarditis Market Size (2015-2020)
11.2 Pericarditis Key Players in India (2019-2020)
11.3 India Pericarditis Market Size by Type (2015-2020)
11.4 India Pericarditis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pericarditis Market Size (2015-2020)
12.2 Pericarditis Key Players in Central & South America (2019-2020)
12.3 Central & South America Pericarditis Market Size by Type (2015-2020)
12.4 Central & South America Pericarditis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Pericarditis Introduction
13.1.4 Pfizer Revenue in Pericarditis Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Astrazeneca
13.2.1 Astrazeneca Company Details
13.2.2 Astrazeneca Business Overview
13.2.3 Astrazeneca Pericarditis Introduction
13.2.4 Astrazeneca Revenue in Pericarditis Business (2015-2020)
13.2.5 Astrazeneca Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Pericarditis Introduction
13.3.4 Bayer Revenue in Pericarditis Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Reckitt Benckiser
13.4.1 Reckitt Benckiser Company Details
13.4.2 Reckitt Benckiser Business Overview
13.4.3 Reckitt Benckiser Pericarditis Introduction
13.4.4 Reckitt Benckiser Revenue in Pericarditis Business (2015-2020)
13.4.5 Reckitt Benckiser Recent Development
13.5 Perkinelmer
13.5.1 Perkinelmer Company Details
13.5.2 Perkinelmer Business Overview
13.5.3 Perkinelmer Pericarditis Introduction
13.5.4 Perkinelmer Revenue in Pericarditis Business (2015-2020)
13.5.5 Perkinelmer Recent Development
13.6 Fujifilm
13.6.1 Fujifilm Company Details
13.6.2 Fujifilm Business Overview
13.6.3 Fujifilm Pericarditis Introduction
13.6.4 Fujifilm Revenue in Pericarditis Business (2015-2020)
13.6.5 Fujifilm Recent Development
13.7 Merck Sharp & Dohme
13.7.1 Merck Sharp & Dohme Company Details
13.7.2 Merck Sharp & Dohme Business Overview
13.7.3 Merck Sharp & Dohme Pericarditis Introduction
13.7.4 Merck Sharp & Dohme Revenue in Pericarditis Business (2015-2020)
13.7.5 Merck Sharp & Dohme Recent Development
13.8 Allergan
13.8.1 Allergan Company Details
13.8.2 Allergan Business Overview
13.8.3 Allergan Pericarditis Introduction
13.8.4 Allergan Revenue in Pericarditis Business (2015-2020)
13.8.5 Allergan Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pericarditis Key Market Segments
Table 2. Key Players Covered: Ranking by Pericarditis Revenue
Table 3. Ranking of Global Top Pericarditis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pericarditis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Pericarditis
Table 6. Key Players of Chronic Pericarditis
Table 7. Key Players of Recurrent Pericarditis
Table 8. Global Pericarditis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Pericarditis Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Pericarditis Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Pericarditis Market Share by Regions (2015-2020)
Table 12. Global Pericarditis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Pericarditis Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Pericarditis Market Growth Strategy
Table 18. Main Points Interviewed from Key Pericarditis Players
Table 19. Global Pericarditis Revenue by Players (2015-2020) (Million US$)
Table 20. Global Pericarditis Market Share by Players (2015-2020)
Table 21. Global Top Pericarditis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis as of 2019)
Table 22. Global Pericarditis by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pericarditis Product Solution and Service
Table 25. Date of Enter into Pericarditis Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 28. Global Pericarditis Market Size Share by Type (2015-2020)
Table 29. Global Pericarditis Revenue Market Share by Type (2021-2026)
Table 30. Global Pericarditis Market Size Share by Application (2015-2020)
Table 31. Global Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 32. Global Pericarditis Market Size Share by Application (2021-2026)
Table 33. North America Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Pericarditis Market Share (2019-2020)
Table 35. North America Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 36. North America Pericarditis Market Share by Type (2015-2020)
Table 37. North America Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 38. North America Pericarditis Market Share by Application (2015-2020)
Table 39. Europe Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Pericarditis Market Share (2019-2020)
Table 41. Europe Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Pericarditis Market Share by Type (2015-2020)
Table 43. Europe Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Pericarditis Market Share by Application (2015-2020)
Table 45. China Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 46. China Key Players Pericarditis Market Share (2019-2020)
Table 47. China Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 48. China Pericarditis Market Share by Type (2015-2020)
Table 49. China Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 50. China Pericarditis Market Share by Application (2015-2020)
Table 51. Japan Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Pericarditis Market Share (2019-2020)
Table 53. Japan Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Pericarditis Market Share by Type (2015-2020)
Table 55. Japan Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Pericarditis Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Pericarditis Market Share (2019-2020)
Table 59. Southeast Asia Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Pericarditis Market Share by Type (2015-2020)
Table 61. Southeast Asia Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Pericarditis Market Share by Application (2015-2020)
Table 63. India Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 64. India Key Players Pericarditis Market Share (2019-2020)
Table 65. India Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 66. India Pericarditis Market Share by Type (2015-2020)
Table 67. India Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 68. India Pericarditis Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Pericarditis Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Pericarditis Market Share (2019-2020)
Table 71. Central & South America Pericarditis Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Pericarditis Market Share by Type (2015-2020)
Table 73. Central & South America Pericarditis Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Pericarditis Market Share by Application (2015-2020)
Table 75. Pfizer Company Details
Table 76. Pfizer Business Overview
Table 77. Pfizer Product
Table 78. Pfizer Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 79. Pfizer Recent Development
Table 80. Astrazeneca Company Details
Table 81. Astrazeneca Business Overview
Table 82. Astrazeneca Product
Table 83. Astrazeneca Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 84. Astrazeneca Recent Development
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Product
Table 88. Bayer Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 89. Bayer Recent Development
Table 90. Reckitt Benckiser Company Details
Table 91. Reckitt Benckiser Business Overview
Table 92. Reckitt Benckiser Product
Table 93. Reckitt Benckiser Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 94. Reckitt Benckiser Recent Development
Table 95. Perkinelmer Company Details
Table 96. Perkinelmer Business Overview
Table 97. Perkinelmer Product
Table 98. Perkinelmer Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 99. Perkinelmer Recent Development
Table 100. Fujifilm Company Details
Table 101. Fujifilm Business Overview
Table 102. Fujifilm Product
Table 103. Fujifilm Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 104. Fujifilm Recent Development
Table 105. Merck Sharp & Dohme Company Details
Table 106. Merck Sharp & Dohme Business Overview
Table 107. Merck Sharp & Dohme Product
Table 108. Merck Sharp & Dohme Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 109. Merck Sharp & Dohme Recent Development
Table 110. Allergan Business Overview
Table 111. Allergan Product
Table 112. Allergan Company Details
Table 113. Allergan Revenue in Pericarditis Business (2015-2020) (Million US$)
Table 114. Allergan Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pericarditis Market Share by Type: 2020 VS 2026
Figure 2. Acute Pericarditis Features
Figure 3. Chronic Pericarditis Features
Figure 4. Recurrent Pericarditis Features
Figure 5. Global Pericarditis Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Medical Institutes Case Studies
Figure 8. Research Organization Case Studies
Figure 9. Pericarditis Report Years Considered
Figure 10. Global Pericarditis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pericarditis Market Share by Regions: 2020 VS 2026
Figure 12. Global Pericarditis Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pericarditis Market Share by Players in 2019
Figure 15. Global Top Pericarditis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pericarditis as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pericarditis Revenue in 2019
Figure 17. North America Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Pericarditis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…- リウマチ性心臓病の世界市場（～2026年） Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged. Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expen…
- 多形性膠芽腫（GBM）再発治療の世界市場（～2026年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…
- 慢性特発性骨髄線維症の世界市場（～2026年） Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…
- 慢性疲労症候群治療の世界市場（～2026年） Chronic fatigue syndrome is not a simple problem for any individual, it’s a complex disorder which is considered as thrilling fatigue, which cannot be able to explain by medical conditions. Chronic fatigue syndrome which can prime to deterioration of creatively suffering and harm of quality of life,…